ERP Inventory for Pharmaceutical Manufacturers: DSCSA Serialization, Lot Traceability, and AI Compliance Automation
No ERP replacement. The manufacturer owns it at completion.
DSCSA serialization records, 21 CFR Part 11 audit trails, quarantine enforcement, controlled substance transaction logging and AI-powered compliance automation, connected to the ERP already running in the facility.
Book a Discovery Call→
Featured ›
Featured ›
Client
Featured ›
Featured ›
Featured ›
Partner
Member
Featured ›
Featured ›
Featured ›
Featured ›
Featured ›
Featured ›
Featured ›
Featured ›
Featured ›
Featured ›
Featured ›
Featured ›What Pharmaceutical ERP Inventory Requires That Standard Inventory Systems Cannot Provide
Pharmaceutical ERP inventory is not about tracking quantities across warehouse locations. It is about maintaining a GMP-compliant, electronically signed, immutable record of every lot, through every inventory movement, from raw material COA, through quarantine hold, QC release, production consumption and outbound chain of custody, in a format that meets 21 CFR Part 11, DSCSA and DEA audit requirements all at the same time.
This is precisely what makes pharmaceutical ERP software different from a regular inventory system. An ERP for the pharmaceutical industry must address five requirements.
Lot Genealogy
Every raw material lot must be traceable to the production batches that used it and the finished goods produced from it. Transactions must have operator IDs, timestamps, signatures, and an audit trail where applicable.
DSCSA Serialization
Serialized products must have identifiers and traceability records that allow for electronic tracing and FDA verification requests.
Quarantine Enforcement
Received materials can be placed in quarantine status, and the pharmaceutical ERP will not allow them to be used in production until QC release.
DEA Controlled Substance Records
Schedule II to V stock must have detailed records of receipts, transfers, dispensing, balances, dates and personnel authorized to handle it. Required inventory documentation must be maintained.
Chain of Custody
Distribution records should identify the person who transferred or received pharmaceutical products, the date of transfer, and the relevant product and quantity data.
The main difference is control. A standard ERP may track inventory movement, but a pharmaceutical ERP must also track the compliance evidence behind that movement.
DSCSA Serialization and Traceability in ERP: What the Records Must Contain
The Drug Supply Chain Security Act (DSCSA) requires pharmaceutical manufacturers and distributors to serialize covered prescription drugs at the package level and to maintain electronic traceability records across trading partners. The ERP, along with the relevant DSCSA compliance software, must be able to provide access to these records in response to FDA tracing or verification requests.
Pharmaceutical serialization and traceability at the package level revolves around four key data elements.
NDC
Identifies the specific drug and package configuration.
Serial Number
Identifies an individual package within a lot.
Lot Number
Links the package to the batch it was produced in.
Expiration Date
Shows the date when the product expires.
Together, these make up the DSCSA product identifier, typically encoded in a standard 2D data matrix barcode on each package. The traceability record also contains transaction information: product identification, quantities, transaction and shipment dates, and information on the trading partners involved in the transfer.
DSCSA also historically utilized Transaction History and Transaction Statement records, though current enhanced electronic tracing requirements center on interoperable electronic transaction information and transaction statements.
EPCIS Is the Exchange Standard
Electronic Product Code Information Services (EPCIS) is the GS1 standard commonly used to exchange serialized supply chain event data. An ERP integration can create or consume EPCIS events when products are commissioned, packed, aggregated, shipped, and received, maintaining the electronic traceability trail. This is where pharmaceutical serialization and lot traceability software intersect: the serialized package record must remain linked to its lot, transaction history, and supply chain events.
Quarantine Hold and QC Release Workflows in Pharmaceutical ERP
Quarantine hold is not just a status flag in the ERP. It is an enforced restriction that must prevent downstream use of a lot until QC specifically releases it. A pharma inventory compliance gap exists when an ERP puts a lot into "quarantine" but still allows a production order to be issued against it.
Deviation holds should also be clearly distinct from an initial quarantine hold. A deviation hold may be used after a temperature excursion, an out-of-specification process result or a production nonconformance. The ERP should link that hold to the deviation record, investigation and final disposition so that the reason for restricting the lot is still traceable.
Automatic Quarantine at Receipt
In a well-configured pharmaceutical ERP system, incoming material would automatically be assigned quarantine status upon receipt.
Production picking against that restricted lot is blocked, and the same material status must flow to the WMS so it cannot direct an operator to pick the lot.
Incoming Inspection and Testing
The QC release process begins after incoming inspection and testing.
QC documents the results in the appropriate quality or LIMS system and makes the release decision.
Release, Conditional Release or Reject
Depending on the configured workflow, the lot will either be released, conditionally released or rejected.
Each outcome carries a different downstream restriction on how the material can be used.
Audit Trail on Every Status Change
Where approvals and status changes are controlled, they should provide the required audit trail.
Including the authorized user, timestamp, decision and electronic signature where applicable.
Controlled Disposition of Rejected Material
Rejected material then goes through a controlled disposition process.
Such as return to supplier, rework, or destruction.
DEA Controlled Substance Records in Pharmaceutical ERP
For DEA Schedule II to V materials, in addition to normal inventory balance, transaction level records are required in the ERP. Manufacturers and distributors need records that will account for controlled substances received, manufactured, distributed, transferred, returned, or destroyed under 21 USC 827 and related DEA recordkeeping requirements.
Good controlled substance inventory software should record pertinent transaction information such as the supplier or recipient information, DEA registration information where applicable, quantity, lot, date of transaction, and authorized personnel.
An AI monitoring layer can be added to review transaction history for suspicious activity, for example high transaction velocity, unexplained differences in balances, or missing links between receipts and subsequent inventory movements.
Exceptions Reviewed Before They Become Findings
These exceptions can then be explored further before they become audit findings.
Transaction Level Records
Records that account for controlled substances received, manufactured, distributed, transferred, returned, or destroyed.
Under 21 USC 827 and related DEA recordkeeping requirements.
Form 222, Form 41 and Form 106
You have to use either the correct DEA Form 222 or the DEA's electronic ordering process to order and transfer Schedule I and II substances.
Destruction records may need to be documented on DEA Form 41, depending on the circumstances. Significant losses or theft may require reporting on DEA Form 106.
Running Balance, Reconciled to Stock
The ERP must maintain a running inventory balance of controlled substances.
And that balance has to be reconcilable to physical stock.
Biennial Inventory and Discrepancies
DEA registrants generally must conduct a controlled substances inventory every two years, with exact counts required for Schedule II substances.
The ERP should allow manual entry of counts, reconciliation, investigation of discrepancies and maintenance of the required inventory records.
Does your ERP block production against a quarantined lot?
Many mark the status but still allow the issue. Tell us which ERP you run and where the enforcement gap sits.
Book a Discovery Call→Chain of Custody in Pharmaceutical Distribution ERP
DSCSA chain of custody is more than a shipping log. It is the electronic traceability record showing the movement of a pharmaceutical product between authorized trading partners. Effective pharmaceutical serialization and traceability links each serialized product to the transaction and supply chain events needed to investigate its movement. The ERP and the associated pharmaceutical traceability software should support three key controls.
Authorized Trading Partner Verification
The organization must verify the trading partner is properly authorized under DSCSA before a covered transaction.
The system must retain existing authorization information and stop transfers when the required credentials cannot be confirmed.
Suspect Product Handling
All products determined to be suspect should be quarantined while the necessary investigation and DSCSA verification steps are executed.
If the product is found to be illegitimate, the appropriate FDA and trading partner notification process should be followed.
Saleable Returns
Returned products subject to DSCSA requirements must be verified before re-entry into saleable inventory.
The verification result and its supporting record stay attached to the serialized package.
Much of this traceability is enabled by the electronic event structure offered by EPCIS. Manufacturers can create events for commissioning, packaging and aggregation, and shipping. Distributors record receiving and shipping events. These records must be searchable and retrievable when responding to information requests from the FDA.
AI in Pharmaceutical ERP Inventory: Three Specific Compliance Mechanisms
AI in pharmaceutical ERP inventory does not substitute for compliance requirements. It takes on the manual documentation burden and the human-error surface area that generates compliance findings. In practice, artificial intelligence can be used in three specific ways in pharmaceutical ERP software.
Agentic DSCSA and 21 CFR Part 11 Documentation Assembly
An agentic pharma compliance AI is able to receive a request for documentation and assemble the supporting records from the ERP. It can pull EPCIS events, serialized product data, transaction history and current status for a DSCSA verification request.
It can capture electronic records, modification history, timestamps and electronic signatures for review in a 21 CFR Part 11 audit. That means less manual effort spent querying systems and compiling records.
AI Expiry Velocity Monitoring Across Lots
The ML model can match the historical consumption rate with the expiry date of each active lot. If the projected consumption shows that some stock could be left as the expiry date approaches, the system flags the lot for review.
Inventory teams can then look at actions such as accelerated distribution, supplier return where allowed, or destruction planning.
Quarantine Duration Prediction for Production Scheduling
AI can evaluate historical QC results, supplier information, material details, batch information and incoming inspection data. That provides planners with an early warning when an incoming lot resembles batches with past extended holds or failures.
This use of AI in the pharmaceutical supply chain does not release or reject the material. That decision is still made by authorized personnel. The model provides production teams with the lead time to reschedule before a potential QC delay becomes a material shortage.
These mechanisms bring intelligence to an ERP for the pharmaceutical industry while keeping regulated decisions and records inside the established workflows. See how ERP AI automation can connect these processes.
What GrayCyan Builds for Pharmaceutical ERP Inventory
GrayCyan builds enterprise resource planning inventory augmentation for pharmaceuticals that connects to the ERP running in the facility.
It adds DSCSA serialization records, 21 CFR Part 11 audit trails, quarantine enforcement, controlled substance transaction logging and AI-powered compliance automation without replacing the ERP.
What GrayCyan builds:
- DSCSA EPCIS event generation: events such as commission, pack, ship and receive are generated from serialized ERP production and shipping data and stored for retrieval on FDA request.
- 21 CFR Part 11 transaction records: audit trails that capture operator ID, timestamp, electronic signature and transaction history for regulated inventory events.
- Quarantine enforcement middleware: quarantine and deviation status synchronized between ERP and WMS, so restricted lots cannot be picked for production or warehouse movement.
- DEA controlled substance transaction logging: Schedule II to V support for records of receipts, transfers, dispensing, destruction, balance reconciliation and biennial inventory.
- Agentic compliance documentation: on request, AI agents compile DSCSA, audit trail and lot traceability records using ERP data.
- AI expiry and QC monitoring: ML models identify lots approaching expiry and flag incoming lots more likely to require extended QC holds.
When each system is built, the manufacturer owns it outright. There are no ongoing GrayCyan software license fees. For warehouse execution workflows, see WMS for pharmaceutical.
Who This Is Right For
This service is for pharma manufacturers and distributors who already have an ERP, but need stronger inventory compliance, traceability and automation around it.
Manufacturers, CDMOs and API Producers
Who need DSCSA serialization and 21 CFR Part 11 audit trails without changing their ERP.
Pharma Distributors and 3PLs
Requiring chain of custody records and authorized trading partner verification.
DEA Schedule II to V Manufacturers
Needing transaction-level recordkeeping and support for biennial inventories.
Manual Documentation Assembly
Operations where DSCSA, QC release or lot traceability documentation is still assembled from ERP exports by hand.
Not the right fit:
- Large pharmaceutical companies that have already built and validated ERP compliance infrastructure and have IT teams in place.
- Retail and dispensing pharmacies.
- Operations without electronic lot records or an ERP. A data foundation comes first.
For receiving, putaway, picking, and other warehouse execution requirements, see WMS for pharmaceutical.
Frequently Asked Questions: ERP Inventory for Pharmaceutical
Need DSCSA-Compliant ERP Inventory Without Replacing Your Existing System?
Let us know what ERP you run, what DSCSA obligations apply to your operation, whether you manufacture, distribute or both, and where controlled substance or lot traceability records are still done manually.
GrayCyan will show you how pharmaceutical ERP inventory augmentation can meet those obligations on your existing infrastructure, without having to replace the systems you already use.
See WMS for pharmaceutical or start with an AI Readiness Assessment →